Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1987-07-10
1988-11-29
Lee, Mary C.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514351, 514352, 514357, 514332, 546291, 546300, 546301, 546302, 546303, 546304, 546305, 546309, 546329, 546331, 546334, 546255, 546264, 546266, C07D21300, A61K 3144
Patent
active
047882069
ABSTRACT:
Compounds of the formula ##STR1## Y is O ir S, *A is paraphenylene or *----(CH.sub.2)n----(X).sub.m --(CH.sub.2).sub.r ----, X is O, S or --CH.dbd.CH--, n or r, independently, are integers from 0 to 3, s is an integer from 0 to 1, m is an integer from 0 to 1, provided that when m is 1, n+s must be at least 2, R.sub.1 and R.sub.2, independently, are hydrogen, lower alkyl, cycloalkyl, lower alkenyl, Het, aryl, R.sub.3, R.sub.4 and R.sub.8, independently, are hydrogen, lower alkyl, aryl, R.sub.5 and R.sub.6, independently, are hydrogen or lower alkyl, R.sub.7 is hydrogen, lower alkyl, cycloalkyl, Het-lower alkyl or aryl, Het is a monocyclic 5- or 6-membered hetero aromatic or a bicyclic heteroaromatic radical containing one or two hetero atoms selected from nitrogen, oxygen and sulfur, which radical may be substituted by lower alkyl, halogen or aryl, and the asterisk denotes the point of attachment,
and when R.sub.6 and R.sub.7 are different, their enantiomers and racemic mixtures thereof, when R.sub.1 and R.sub.2 are different, their geometric isomers, and pharmaceutically acceptable acid addition salts thereof, are described.
The compounds of formula I exhibit activity as platelet activating factor (PAF) antagonists and are, therefore, useful in disease states characerized by excess platelet activating factor or for the prevention and treatment of cardiovascular disease, pulmonary diseases, immunological disorders, inflammatory diseases, dermatological disorders, shock or transplant rejection.
REFERENCES:
patent: 3072649 (1963-01-01), Semb et al.
patent: 4542145 (1985-09-01), Wright, Jr. et al.
patent: 4568685 (1986-02-01), Wright, Jr. et al.
patent: 4568687 (1986-02-01), Wright, Jr. et al.
Chemical Abstracts; CA 104:168177c, 1986.
Chemical Abstracts; 107:154084v, 1987.
Chemical Abstracts; 97:6167j, 1982.
Japanese 82-81, 973, C.A. 96:178,218x.
5-Phenyl-2,4-Pentadienamides as Potential Antimalarial Agents, Werbel et al, Journal of Med. Chem., vol. 10, pp. 366-370.
Guthrie Robert W.
Kierstead Richard W.
Tilley Jefferson W.
Hoffmann-La Roche Inc.
Isgro William G.
Lee Mary C.
Leon Bernard S.
Northington Zinna
LandOfFree
Pentadieneamides does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Pentadieneamides, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pentadieneamides will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-363813